Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis

被引：0
|
作者：
Quan Wang
Xiaoquan Ji
Jing Sun
Wengang Li
Xuezhang Duan
Aimin Zhang
机构：
[1] The Fifth Medical Center of PLA General Hospital,Department of Radiation Oncology, Senior Department of Oncology
[2] Southern Medical University,The Second School of Clinical Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Advanced hepatocellular carcinoma; Macrovascular invasion; Stereotactic body radiotherapy; Lenvatinib;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7441 / 7452
页数：11
相关论文
共 50 条
  • [1] Comparison of stereotactic body radiotherapy with and without lenvatinib for advanced hepatocellular carcinoma: a propensity score analysis
    Wang, Quan
    Ji, Xiaoquan
    Sun, Jing
    Li, Wengang
    Duan, Xuezhang
    Zhang, Aimin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7441 - 7452
  • [2] Stereotactic body radiotherapy versus lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity matching score analysis
    Ji, Xiaoquan
    Zhang, Aimin
    Duan, Xuezhang
    Wang, Quan
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [3] Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Chiang, Chi-Leung
    Chiu, Keith Wan-Hang
    Lee, Francis Ann-Shing
    Kong, Feng-Ming Spring
    Chan, Albert Chi-Yan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis
    Sun, Jing
    Wang, Quan
    Hong, Zhi-Xian
    Li, Wen-Gang
    He, Wei-Ping
    Zhang, Tao
    Zhang, Ai-Min
    Fan, Yu-Ze
    Sun, Ying-Zhe
    Zheng, Li
    Duan, Xue-Zhang
    HEPATOLOGY INTERNATIONAL, 2020, 14 (05) : 788 - 797
  • [5] Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis
    Jing Sun
    Quan Wang
    Zhi-Xian Hong
    Wen-Gang Li
    Wei-Ping He
    Tao Zhang
    Ai-Min Zhang
    Yu-Ze Fan
    Ying-Zhe Sun
    Li Zheng
    Xue-Zhang Duan
    Hepatology International, 2020, 14 : 788 - 797
  • [6] Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta-analysis of propensity score studies
    Eriguchi, Takahisa
    Takeda, Atsuya
    Tateishi, Yudai
    Tsurugai, Yuichiro
    Sanuki, Naoko
    Ebinuma, Hirotoshi
    Horita, Nobuyuki
    HEPATOLOGY RESEARCH, 2021, 51 (07) : 813 - 822
  • [7] Radiofrequency ablation versus stereotactic body radiotherapy for recurrent hepatocellular carcinoma: a multicenter, propensity score matching analysis
    Ma, Zi-Hui
    Lin, Xiao-Lu
    Liu, Feng-Hua
    Zhang, Jing-Lei
    Yan, Mao-Lin
    Song, Xing-Chao
    Guo, Lei
    Xue, Jie
    Lu, Chong-De
    Shi, Jie
    Meng, Yan
    Cheng, Shu-Qun
    Guo, Wei-Xing
    BMC CANCER, 2025, 25 (01)
  • [8] The efficacy of radical hepatectomy versus stereotactic body radiotherapy for primary hepatocellular carcinoma: A propensity score matching analysis
    Hu, Yulin
    Kong, Feng-Ming Spring
    Ji, Ren
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] STEREOTACTIC BODY RADIOTHERAPY VERSUS RADIOFREQUENCY ABLATION FOR SINGLE SMALL HEPATOCELLULAR CARCINOMA: A PROPENSITY SCORE MATCHING ANALYSIS
    Ueno, Masayuki
    Takabatake, Hiroyuki
    Kayahara, Takahisa
    Morimoto, Youichi
    Mizuno, Motowo
    HEPATOLOGY, 2020, 72 : 708A - 709A
  • [10] Lenvatinib with or without stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a retrospective study
    Ji, Xiaoquan
    Xu, Zhe
    Sun, Jing
    Li, Wengang
    Duan, Xuezhang
    Wang, Quan
    RADIATION ONCOLOGY, 2023, 18 (01)
12345